People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Other Technology, Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Sgrouples, Inc. | — | Other Technology | Seed | $11.9M | $133.1M | 2011 |
| Strategikon Pharma, Inc. | — | Pharma | Seed | $3.3M | $7.0M | 2025 |
Mark Weinstein at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark Weinstein on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Nathanael Lentz | 1 | 10 |
| Jonathan Wolfe | 1 | 1 |
| Rob Hess | 1 | 1 |
| Anca Copaescu | 1 | 1 |
| Debra Apruzzese | 1 | 1 |
| Chris Codeanne | 1 | 1 |
| Paulo Carvalho | 1 | 1 |
| Vincent Lepreux | 1 | 1 |
| Mark Di Ianni | 1 | 1 |
| SHION DEYSARKAR | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.